Company Valuation: Moderna, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Capitalization 1 102,976 69,006 37,919 16,001 11,523 19,458 - -
Change - -32.99% -45.05% -57.8% -27.99% 68.87% - -
Enterprise Value (EV) 1 92,848 59,104 29,315 8,976 5,724 15,899 17,185 17,563
Change - -36.34% -50.4% -69.38% -36.23% 177.77% 8.09% 2.2%
P/E ratio 8.98x 8.93x -8.07x -4.48x -4.06x -5.67x -10.4x -17.2x
PBR 7.24x 3.7x 2.74x 1.46x 1.33x 3.45x 4.74x 5.58x
PEG - -0.3x 0x 0.2x 0.2x -0.3x 0.2x 0.4x
Capitalization / Revenue 5.58x 3.58x 5.54x 4.94x 5.93x 9.33x 7.69x 6.06x
EV / Revenue 5.03x 3.07x 4.28x 2.77x 2.94x 7.62x 6.8x 5.47x
EV / EBITDA 6.86x 6.05x -8.1x -2.39x -2x -4.64x -9.55x -16.9x
EV / EBIT 6.98x 6.27x -6.92x -2.28x -1.86x -4.4x -8.6x -14.5x
EV / FCF 6.96x 12.9x -7.66x -2.21x -2.77x -5.13x -11.6x -13.7x
FCF Yield 14.4% 7.75% -13% -45.2% -36.1% -19.5% -8.63% -7.28%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 28.29 20.12 -12.33 -9.28 -7.26 -8.653 -4.727 -2.852
Distribution rate - - - - - - - -
Net sales 1 18,471 19,263 6,848 3,236 1,944 2,086 2,529 3,213
EBITDA 1 13,528 9,768 -3,618 -3,756 -2,859 -3,425 -1,800 -1,038
EBIT 1 13,296 9,420 -4,239 -3,945 -3,074 -3,616 -1,997 -1,207
Net income 1 12,202 8,362 -4,714 -3,561 -2,822 -3,409 -1,839 -1,148
Net Debt 1 -10,128 -9,902 -8,604 -7,025 -5,799 -3,559 -2,273 -1,895
Reference price 2 253.98 179.62 99.45 41.58 29.49 49.04 49.04 49.04
Nbr of stocks (in thousands) 405,450 384,180 381,284 384,818 390,734 396,786 - -
Announcement Date 24/02/22 23/02/23 22/02/24 14/02/25 13/02/26 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-5.67x7.62x-4.64x-.--% 19.46B
18.08x3.98x10.73x0.56% 71.04B
25.71x5.16x14.88x0.62% 52.43B
34.46x11.78x21.81x-.--% 43.84B
-126.06x2.76x8.16x4.1% 33.99B
31.15x3.41x10.25x-.--% 28.49B
14.44x2.49x7.74x-.--% 19.04B
48.1x5.99x42.14x-.--% 18.17B
24.28x5.11x13.78x-.--% 16.16B
60.32x40.06x52.44x0.1% 13.18B
Average 12.48x 8.84x 17.73x 0.54% 31.58B
Weighted average by Cap. 9.41x 6.89x 15.21x 0.67%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. MRNA Stock
  4. Valuation Moderna, Inc.